Torrent Pharma to acquire a 75.2% stake in JB Chemicals & Pharmaceuticals for $2.3bn.

Torrent Pharma, an Indian pharmaceutical company, offered to acquire a 75.2% stake in JB Chemicals & Pharmaceuticals, an Indian pharmaceutical company specializing in branded formulations, for $2.3bn. "Over the past five years, JB Pharma has emerged as one of India's fastest growing pharmaceutical players, owing to KKR's strategic guidance, stewardship of our independent directors and a focused strategic and executional excellence by the management team. As we now enter a new chapter alongside Torrent Pharmaceuticals, we are confident that the combined strengths of our organizations will unlock greater opportunities to enhance healthcare access across our markets," Nikhil Chopra, JB Pharma CEO.